T.B. Vree

713 total citations
29 papers, 504 citations indexed

About

T.B. Vree is a scholar working on Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, T.B. Vree has authored 29 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 7 papers in Molecular Biology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in T.B. Vree's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Epilepsy research and treatment (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). T.B. Vree is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Epilepsy research and treatment (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). T.B. Vree collaborates with scholars based in Netherlands, United States and Belgium. T.B. Vree's co-authors include P. J. M. Guelen, J. J. Driessen, A. M. Baars, E.W. Wuis, M.J.M. Gielen, Mariella Simon, M. Gore, P A Speth, Piet L. C. M. van Riel and M. A. vanʼt Hof and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, British Journal of Anaesthesia and Lara D. Veeken.

In The Last Decade

T.B. Vree

27 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.B. Vree Netherlands 13 120 117 99 74 61 29 504
E. F. S. Termond Netherlands 12 76 0.6× 124 1.1× 53 0.5× 88 1.2× 79 1.3× 25 541
William R. Thoden United States 13 49 0.4× 132 1.1× 122 1.2× 33 0.4× 47 0.8× 23 503
Thomas J. Comstock United States 13 23 0.2× 104 0.9× 64 0.6× 122 1.6× 25 0.4× 20 539
B. R. Kuhnert United States 15 66 0.6× 42 0.4× 136 1.4× 136 1.8× 11 0.2× 40 571
K. Danielson Sweden 13 50 0.4× 94 0.8× 111 1.1× 235 3.2× 99 1.6× 17 626
David Upmalis United States 16 423 3.5× 165 1.4× 337 3.4× 80 1.1× 36 0.6× 38 1.1k
D. W. Eastwood United States 13 130 1.1× 17 0.1× 142 1.4× 50 0.7× 41 0.7× 35 516
Hartley C. Atkinson New Zealand 11 64 0.5× 85 0.7× 78 0.8× 68 0.9× 43 0.7× 16 325
James A. Forbes United States 20 331 2.8× 495 4.2× 327 3.3× 62 0.8× 107 1.8× 39 843
Charles McKay United States 11 32 0.3× 79 0.7× 45 0.5× 30 0.4× 41 0.7× 26 610

Countries citing papers authored by T.B. Vree

Since Specialization
Citations

This map shows the geographic impact of T.B. Vree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.B. Vree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.B. Vree more than expected).

Fields of papers citing papers by T.B. Vree

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.B. Vree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.B. Vree. The network helps show where T.B. Vree may publish in the future.

Co-authorship network of co-authors of T.B. Vree

This figure shows the co-authorship network connecting the top 25 collaborators of T.B. Vree. A scholar is included among the top collaborators of T.B. Vree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.B. Vree. T.B. Vree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vree, T.B., et al.. (1999). Absolute bioavailability, pharmacokinetics, renal and biliary clearance of distigmine after a single oral dose in comparison to i.v. administration of 14C-distigmine-bromide in healthy volunteers.. PubMed. 37(8). 393–403. 14 indexed citations
2.
Vree, T.B., et al.. (1997). Disposition kinetics of a severe overdose of carbamazepine.. Radboud Repository (Radboud University). 1 indexed citations
3.
Simon, Mariella, et al.. (1997). Intravenous regional anesthesia with 0.5% articaine, 0.5% lidocaine, or 0.5% prilocaineA double-blind randomized clinical study. Regional Anesthesia & Pain Medicine. 22(1). 29–34. 44 indexed citations
4.
Vree, T.B., et al.. (1995). The bioavailability of intramuscularly administered nicomorphine (Vilan) with its metabolites and their glucuronide conjugates in surgical patients.. PubMed. 33(8). 442–8. 3 indexed citations
6.
Vree, T.B., et al.. (1992). Capacity-limited renal glucuronidation of probenecid by humans. Pharmacy World & Science. 14(5). 325–331. 15 indexed citations
7.
Driessen, J. J., T.B. Vree, & P. J. M. Guelen. (1991). The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients.. PubMed. 42(3). 149–55. 55 indexed citations
8.
Onghena, Patrick, et al.. (1990). NEU volume 2 issue 4 Cover and Front matter. Acta Neuropsychiatrica. 2(4). f1–f3. 1 indexed citations
9.
Vree, T.B., A. M. Baars, & E.W. Wuis. (1990). HPLC analysis and pharmacokinetics of the enantiomers of R,S-oxazepam and R,S-temazepam with their corresponding glucuronide conjugates in urine and plasma of man. Acta Neuropsychiatrica. 2(4). 95–100. 4 indexed citations
10.
Wijnands, W. J. A., et al.. (1990). Ciprofloxacin does not impair the elimination of diazepam in humans.. Drug Metabolism and Disposition. 18(6). 954–957. 6 indexed citations
11.
Wuis, E.W., T.B. Vree, & Eppo van der Kleijn. (1990). Pharmacokinetics of intravenously administered dantrolene and its 5-hydroxy metabolite in dogs.. PubMed. 10(4). 203–10. 6 indexed citations
12.
Vree, T.B., et al.. (1989). Pharmacokinetics, metabolism, and renal excretion of articaine and its metabolite articainic acid in patients after epidural administration.. PubMed. 6(1). 49–56. 26 indexed citations
13.
Vree, T.B., et al.. (1989). O-demethylation and N4-acetylation of sulfadimethoxine by the snail Cepaea hortensis.. The Japanese Journal of Veterinary Science. 51(2). 364–368. 7 indexed citations
14.
Wuis, E.W., et al.. (1989). Comparison of the pharmacokinetics of intravenously administered rac-baclofen and its (-)-(R)- and (+)-(S)-enantiomers in dogs.. PubMed. 9(4). 239–46. 13 indexed citations
15.
Nouws, J. F. M., et al.. (1988). Pharmacokinetics, metabolism, and renal clearance of sulfadiazine, sulfamerazine, and sulfamethazine and of their N4-acetyl and hydroxy metabolites in calves and cows. American Journal of Veterinary Research. 49(7). 1059–1065. 31 indexed citations
16.
Wijnands, W. J. A., et al.. (1988). Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue. Journal of Antimicrobial Chemotherapy. 21(suppl B). 67–77. 27 indexed citations
17.
Guelen, P. J. M., et al.. (1988). Comparative bioavailability and kinetics of folinic acid in the pharmaceutical formulations of Rescuvolin® and Ledervorin® in healthy volunteers. Biopharmaceutics & Drug Disposition. 9(1). 31–39. 2 indexed citations
18.
Speth, P A, T.B. Vree, P.H.M. de Mulder, et al.. (1987). Propylene Glycol Pharmacokinetics and Effects after Intravenous Infusion in Humans. Therapeutic Drug Monitoring. 9(3). 255–258. 53 indexed citations
19.
Nouws, J. F. M., T.B. Vree, M.M.L. Aerts, & J.L. Grondel. (1986). Pharmacokinetics and residues of sulphadimidine, its N4-acetyl- and hydroxy-metabolites in food producing animals.. Archiv für Lebensmittelhygiene. 37(3). 57–84. 11 indexed citations
20.
Vree, T.B., et al.. (1978). Kinetics of drug interactions in the treatment of epilepsy.. PubMed. 16(10). 467–73. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026